Get startedLog in
    Picture of SurModics logo

    SRDX — SurModics Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for SurModics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

    2020
    September 30th
    2021
    September 30th
    2022
    September 30th
    2023
    September 30th
    2024
    September 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1.124.24-27.3-1.54-11.5
    Depreciation
    Deferred Taxes
    Non-Cash Items5.656.347.927.958.78
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital1.11-4.86-12.3-4.24-5.36
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities1415.4-17.210.50.248
    Capital Expenditures-3.67-6.28-3.37-2.92-3.49
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-5.39-199.6-3.90.555
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-9.07-25.26.23-6.82-2.94
    Financing Cash Flow Items-6.26-2.9-1.62-2.51-4.17
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-4.6510.2-0.37518.4-2.95
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.4240.368-12.222.4-5.3